Contact

Send us your feedback

Thank you for your feedback. An email has been sent to the ESRC support team.

An error occured whilst sending your feedback. Please review the problems below.

Risk, safety and consent in contemporary blood services in the United Kingdom: perspectives from sociology and law

Grant reference: RES-062-23-2751

« View grant details

Journal article details

Risk, innovation and the regulation of health technologies : examining EU governance of blood and plasma products
This paper examines the relationship between risk, innovation and the regulation of health technologies, drawing on a case study of EU governance of blood and plasma products. It is argued that the political context brings complexity to EU regulatory processes, which impacts upon the management of the relationship between risk and innovation. This may be particularly apparent in politically sensitive areas of EU governance where public trust may be at issue, such as those involving health technologies. If the right balance is to be struck between risk and innovation in regulatory governance in this field, then particular attention should be paid to how the political context impacts upon policy framing, the maintenance of regulatory connection in line with core policy objectives and the promotion of regulatory legitimacy.
10.1080/13511610.2012.732743
English

Primary contributor

Author Anne-Maree Farrell

Additional details

25
4
Yes
1351-1610
Routledge, Taylor & Francis Group
19 November 2012
Paperback
461-477
Abingdon
Post-print
Innovation

Cite this outcome

Harvard

Farrell, Anne-Maree (2012) Risk, innovation and the regulation of health technologies : examining EU governance of blood and plasma products. Innovation. 25 (4), pp. 461-477 Abingdon: Routledge, Taylor & Francis Group.

Vancouver

Farrell Anne-Maree. Risk, innovation and the regulation of health technologies : examining EU governance of blood and plasma products. Innovation 2012; 25 (4): 461-477.